IDEAYA Biosciences (NASDAQ: IDYA) is currently in Phase 8 of its 18-phase Adhishthana cycle on the weekly charts. Under the lens of the Adhishthana Principles, the stock’s outlook appears weak, with signs suggesting it may remain range-bound and underperform until May 2029.
Read the full article on Benzinga for deeper insights into the Adhishthana Cycle, the stock’s recent trajectory, and expert commentary.
